STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Results from 'Magnificent Seven' duo show cloud revenue boosted by strong AI demand

Cosmo Pharmaceuticals N.V. (C43.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Add to watchlist

72.50

-2.00

(-2.68%)

As of 05:20PM CEST. Market open.

Loading interactive chart...

Newsfile
Cosmo Announces Leadership Changes
Ad hoc announcement pursuant to Art. 53 LR Giovanni Di Napoli appointed as new CEO effective from 24 May 2024. Current CEO Alessandro Della Chà to be appointed ...
Newsfile
Cosmo and Medtronic Unveil the Future of AI in GI: Genius Summit 2024 Reveals Innovations and Collaborations That Advance Endoscopic Care
Dublin, Ireland--(Newsfile Corp. - April 12, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announces that Medtronic plc (NYSE: MDT), a global leader in healthcare technology, presented at the Genius Summit 2024 the latest advancements in artificial intelligence (AI) for endoscopic care by unveiling ColonPRO™, the latest generation software for the GI Genius™ intelligent endoscopy system ...
Simply Wall St.
Bullish: Analysts Just Made A Massive Upgrade To Their Cosmo Pharmaceuticals N.V. (VTX:COPN) Forecasts
Shareholders in Cosmo Pharmaceuticals N.V. ( VTX:COPN ) may be thrilled to learn that the analysts have just delivered...